CNTM vs PIRS Comparison

ConnectM Technology Solutions Inc is a clean energy technology and solutions provider. The company provides residential and light commercial buildings and all-electric original equipment manufacturers (OEMs) with a proprietary digital platform to accelerate the transition to solar and all-electric heating, cooling and transportation. The group makes electrification more user-friendly, affordable, precise, and socially meaningful by combining technology, data, artificial intelligence, and contemporary design. In addition to its vertically integrated service network, ConnectM offers customers a comprehensive technology stack that enables them to reduce their fossil fuel consumption, lower their energy bills, and decrease their carbon footprint.

Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, which engages in the discovery and development of the Anticalin class of biotherapeutics. Anticalin proteins are engineered versions of lipocalins, human proteins that naturally bind, store, and transport a wide spectrum of molecules. The Company's clinical pipeline consists of immuno-oncology, or IO, bispecifics in partnership with collaborators, including S095012 (also referred to as PRS-344) targeting PD-L1 and 4-1BB, SGN-BB228 (also referred to as PRS-346) targeting CD228 and 4-1BB, and BOS-342 (also referred to as PRS-342) targeting GPC3 and 4-1BB. Geographically, all the operations of the firm function through the region of the United States.